Taiwan Advance Bio-Pharmaceutical Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Taiwan Advance Bio-Pharmaceutical Inc

Watchlist Manager

Watchlist

Price: 7.9 TWD -0.25% Market Closed

Market Cap: NT$711m

T	Taiwan Advance Bio-Pharmaceutical Inc TPEX:4186	TW

Profitability Summary

Taiwan Advance Bio-Pharmaceutical Inc's profitability score is 56/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

68%

Strong 3Y Average Gross Margin

67%

Gross Margin is Increasing

55% > 68%

Healthy Operating Margin

12%

Low 3Y Average Operating Margin

Operating Margin is Increasing

-13% > 12%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

-15% > 6%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All

Hide

Collapse

56 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.